Get informed when a big investor buys or sells
+ FollowOvervalued by 65.9% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $26.28 Billion |
|---|---|
| Enterprise Value | $33.71 Billion |
| Annual dividend | $1.00 |
| Dividend yield | 3.90% |
| Earnings per Share | $0.94 |
| Beta | 0.92 |
| Outstanding Shares | 955,573,000 |
| P/E Ratio | 18.62 |
|---|---|
| PEG | 31.03 |
| Price to Sales | 1.51 |
| Price to Book Ratio | 2.26 |
| Enterprise Value to Revenue | 1.9 |
| Enterprise Value to EBIT | 19.57 |
| Enterprise Value to Net Income | 30 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 0.81 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Koninklijke Philips N.V., a prominent global health technology enterprise, conducts its operations across North America and various international markets. The company's business activities are structured into three primary segments: Diag...